Babaran, Baby Boy .
HRN: 26-97-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/14/2025
05/20/2025
IV
41mg
Q24
T/C Neonatal Pneumonia
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes